Views & Analysis Urgent need for clarity as government suspends pharmacy cut ... But reprieve may last only until plans have been reviewed.
Partner Content Partner Content The new CDF - Navigating Cancer Drug Access in England On July 29th 2016, the new process in England for cancer drugs seeking license went live - changing both the shape and potential requirements of the submissions process.
Debates & Insight Sponsored Brexit - What now for pharma? Join us for a one-hour live webinar entitled Brexit - What now for pharma?
Debates & Insight Sponsored Available on demand: Measuring the cost of the right interve... Available on Demand: Measuring the cost of the right interventions in diabetes.
Debates & Insight Sponsored Available on demand: Cancer Treatment Access: Strategy, Appr... Available on demand: A one-hour live debate on Cancer Treatment Access: Right Strategy, Right Approach, Right Outcomes.
Partner Content Partner Content IMS Health and Reltio Form Alliance to Deploy Advanced Infor... Providing Customers the Best in Big Data Technologies, High-Performance Analytics and Healthcare Information Capabilities
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
